Professional Profile
Xiao Li's practice focuses on patent infringement litigation. She has represented clients in disputes across a range of technologies and industries, including pharmaceutical products, biotechnology, semiconductor technology, and internet technology. Prior to joining Desmarais LLP, Ms. Li was an associate in the Intellectual Property group of Kirkland & Ellis LLP.
Representative Matters
- Represented GlaxoSmithKline against Apotex, Inc. in patent infringement and antitrust litigation involving the prescription antidepressant pharmaceutical Paxil.
- Represented GlaxoSmithKline in consolidated direct and indirect purchaser class action antitrust litigations involving the prescription antidepressant pharmaceutical Wellbutrin XL.
- Represented Forest and Merz in multi-defendant ANDA litigation involving the Alzheimer’s disease pharmaceutical Namenda.
- Represented Forest and Lundbeck in declaratory judgment ANDA action involving the prescription antidepressant pharmaceutical Lexapro.